UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 13, 2026 11:30 A.M.
Form:
S-1
CIK:
0001971387
Company Name:
Liminatus Pharma, Inc.
File Number:
333-293364